A
$ Value
$0
Shares
24,000
Price
$0
Filed
Jun 4
Insider
Name
Vitale Nancy
Title
—
CIK
0001823262
Roles
Director
Transaction Details
Transaction Date
2025-06-03
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
24,000
Footnotes
This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director.
Filing Info
Vitale Nancy's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-03 | VYGR | A | $0 |
Other Insiders at VYGR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sandrock Alfred
President and CEO
|
— | $184K | 2026-04-02 |
|
Jorgensen Nathan D.
Chief Financial Officer
|
— | $18K | 2026-02-24 |
|
Swartz Robin
COO & CBO
|
— | $55K | 2026-02-24 |
|
Carter Todd Alfred
Chief Scientific Officer
|
— | $41K | 2026-02-24 |
|
Ferguson Toby
Chief Medical Officer
|
— | — | 2026-02-06 |
|
Shiferman Gregory L.
SVP and General Counsel
|
— | — | 2026-04-01 |